viewLexagene Holdings Inc.

Full interview: Lexagene makes key hire as they hope to have their LX Analyzer to market in Q-3

Lexagene (CVE: LXG- OTCQB: LXXGF) Co-Founder and CEO Dr Jack Regan joined Steve Darling from Proactive Vancouver to discuss the hiring of Steven Armstrong as the company’s Senior Director of Operations. Regan explains the skills he is bringing to the job.

Regan also told Proactive the latest on manufacturing its flagship LX Genetic Analyzer for rapid pathogen detection. Lexagene recently revealed that it is accelerating the submission of its LX Analyzer to the FDA as the COVID-19 outbreak expands.

Quick facts: Lexagene Holdings Inc.

Price: 0.86 CAD

Market: TSX-V
Market Cap: $73.69 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Lexagene Holdings Inc. named herein, including the promotion by the Company of Lexagene Holdings Inc. in any Content on the Site, the Company...



Amundi Physical Gold ETC: Europe's cheapest ETC now trading on the London...

Amundi Physical Gold ETC's Ashley Fagan who's head of ETF, Indexing & Smart Beta Development for UK and Ireland introduces the product to Proactive London's Andrew Scott. She says they've seen a great deal of demand from European as well as UK investors and that's what lead them to list...

2 days, 9 hours ago

2 min read